Evidence map›Paper›PMID 41160100›Full record

ArticleCurrent microbiology2025

First Report on Biosynthesis of Riboflavin by Microbacterium proteolyticum BWBTDIPO1 - Extraction, Characterization and Mechanistic Insight Via In-Silico Approach.

Indrani Paul, Preeti Rajesh, Subhajit Roy, Payal Guha, Sneha Kali, Tanvi Saha, Subhasree Majumdar, Anjishnu Mukhopadhyay, Manashi Paul

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Indrani PaulDepartment of Biotechnology, Brainware University, Kolkata, 700125, India. dip.bt@brainwareuniversity.ac.in.ORCID http://orcid.org/0000-0001-9165-9430
Preeti RajeshDepartment of Biotechnology, Brainware University, Kolkata, 700125, India. dpr.bt@brainwareuniversity.ac.in.
Subhajit RoyDepartment of Biotechnology, Brainware University, Kolkata, 700125, India.
Payal GuhaDepartment of Biotechnology, Brainware University, Kolkata, 700125, India.
Sneha KaliDepartment of Biotechnology, Brainware University, Kolkata, 700125, India.
Tanvi SahaDepartment of Biotechnology, Brainware University, Kolkata, 700125, India.
Subhasree MajumdarDepartment of Zoology, Sonamukhi College, Sonamukhi, Bankura, 722207, West Bengal, India.
Anjishnu MukhopadhyayDepartment of Biotechnology, St.Aloysius (Deemed to be University), Mangalore, 575003, India.
Manashi PaulFaculty of Science and Humanities, SRM Institute of Science and Technology, Chennai, 603203, India.

Funding

Brainware University BWU/PRJ/SMG/24-25/001
6 · The paper itself

Abstract

The sustainable and cost-effective biosynthesis of valuable nutraceuticals like Riboflavin from natural sources is a major challenge for researchers. Bacterial strains having the potential for Riboflavin overproduction without manipulation in genetic makeup are a rare phenomenon. The present investigation reports for the first time a newly isolated gram-positive, rod-shaped, indigenous bacterial monoculture, identified as Microbacterium proteolyticum (GenBank Acc. No.: PQ517523), to be a promising Riboflavin producer. Growth kinetics recorded the optimum growth in Luria Bertini broth media, where a maximum specific growth rate of 0.887 h

Indexed as

MicrobacteriumRiboflavinComputer SimulationKineticsPhylogenyRNA, Ribosomal, 16SRiboflavinRNA, Ribosomal, 16SBiosynthesisKEGG pathwayMetabolic pathwayMicrobacterium sp.Riboflavin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.